Training in Substance Use Disorders, Part 1: Overview of Clinical Practice Recommendations

Overview

Journal Can J Psychiatry

Specialty Psychiatry

Date 2024 Apr 13

PMID 38613369

Authors

Anees Bahji

David Crockford

Jennifer Brasch

Christian Schutz

Leslie Buckley

Marlon Danilewitz

Simon Dubreucq

Michael Mak

Tony P George

Affiliations

Soon will be listed here.

References

Pollak K, Nagy P, Bigger J, Bilheimer A, Lyna P, Gao X . Effect of teaching motivational interviewing via communication coaching on clinician and patient satisfaction in primary care and pediatric obesity-focused offices. Patient Educ Couns. 2015; 99(2):300-3. DOI: 10.1016/j.pec.2015.08.013. View

Abidi S, Mian I, Garcia-Ortega I, Lecomte T, Raedler T, Jackson K . Canadian Guidelines for the Pharmacological Treatment of Schizophrenia Spectrum and Other Psychotic Disorders in Children and Youth. Can J Psychiatry. 2017; 62(9):635-647. PMC: 5593251. DOI: 10.1177/0706743717720197. View

Saunders J, Aasland O, Babor T, De la Fuente J, Grant M . Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II. Addiction. 1993; 88(6):791-804. DOI: 10.1111/j.1360-0443.1993.tb02093.x. View

Chan B, Gean E, Arkhipova-Jenkins I, Gilbert J, Hilgart J, Fiordalisi C . Retention Strategies for Medications for Opioid Use Disorder in Adults: A Rapid Evidence Review. J Addict Med. 2020; 15(1):74-84. PMC: 7864607. DOI: 10.1097/ADM.0000000000000739. View

Coles A, Sasiadek J, George T . Pharmacotherapies for co-occurring substance use and bipolar disorders: A systematic review. Bipolar Disord. 2019; 21(7):595-610. DOI: 10.1111/bdi.12794. View

Yaden D, Berghella A, Regier P, Garcia-Romeu A, Johnson M, Hendricks P . Classic psychedelics in the treatment of substance use disorder: Potential synergies with twelve-step programs. Int J Drug Policy. 2021; 98:103380. DOI: 10.1016/j.drugpo.2021.103380. View

Kessler R, Crum R, Warner L, Nelson C, Schulenberg J, Anthony J . Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiatry. 1997; 54(4):313-21. DOI: 10.1001/archpsyc.1997.01830160031005. View

Fleury G, Milin R, Crockford D, Buckley L, Charney D, George T . Training in Substance-Related and Addictive Disorders, Part 1: Overview of Clinical Practice and General Recommendations. Can J Psychiatry. 2016; 60(12):1-9. PMC: 4679170. View

Liepman M, Nirenberg T, Doolittle R, Begin A, Broffman T, Babich M . Family functioning of male alcoholics and their female partners during periods of drinking and abstinence. Fam Process. 1989; 28(2):239-49. DOI: 10.1111/j.1545-5300.1989.00239.x. View

10.

Kleber H, Weiss R, Anton Jr R, George T, Greenfield S, Kosten T . Treatment of patients with substance use disorders, second edition. American Psychiatric Association. Am J Psychiatry. 2007; 164(4 Suppl):5-123. View

11.

Babor T, McRee B, Kassebaum P, Grimaldi P, Ahmed K, Bray J . Screening, Brief Intervention, and Referral to Treatment (SBIRT): toward a public health approach to the management of substance abuse. Subst Abus. 2007; 28(3):7-30. DOI: 10.1300/J465v28n03_03. View

12.

Hitsman B, Moss T, Montoya I, George T . Treatment of tobacco dependence in mental health and addictive disorders. Can J Psychiatry. 2009; 54(6):368-78. PMC: 3632078. DOI: 10.1177/070674370905400604. View

13.

Ullman S, Relyea M, Peter-Hagene L, Vasquez A . Trauma histories, substance use coping, PTSD, and problem substance use among sexual assault victims. Addict Behav. 2013; 38(6):2219-23. PMC: 3622163. DOI: 10.1016/j.addbeh.2013.01.027. View

14.

Kennedy S, Lam R, McIntyre R, Tourjman S, Bhat V, Blier P . Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments. Can J Psychiatry. 2016; 61(9):540-60. PMC: 4994790. DOI: 10.1177/0706743716659417. View

15.

McTavish J, Kimber M, Devries K, Colombini M, MacGregor J, Wathen N . Children's and caregivers' perspectives about mandatory reporting of child maltreatment: a meta-synthesis of qualitative studies. BMJ Open. 2019; 9(4):e025741. PMC: 6500368. DOI: 10.1136/bmjopen-2018-025741. View

16.

Maremmani I, Zolesi O, Aglietti M, Marini G, Tagliamonte A, Shinderman M . Methadone dose and retention during treatment of heroin addicts with Axis I psychiatric comorbidity. J Addict Dis. 2000; 19(2):29-41. DOI: 10.1300/J069v19n02_03. View

17.

Mariani J, Levin F . Treatment strategies for co-occurring ADHD and substance use disorders. Am J Addict. 2007; 16 Suppl 1:45-54. PMC: 2676785. DOI: 10.1080/10550490601082783. View

18.

Green A, Drake R, Brunette M, Noordsy D . Schizophrenia and co-occurring substance use disorder. Am J Psychiatry. 2007; 164(3):402-8. DOI: 10.1176/ajp.2007.164.3.402. View

19.

Regier D, Narrow W, Rae D, Manderscheid R, Locke B, Goodwin F . The de facto US mental and addictive disorders service system. Epidemiologic catchment area prospective 1-year prevalence rates of disorders and services. Arch Gen Psychiatry. 1993; 50(2):85-94. DOI: 10.1001/archpsyc.1993.01820140007001. View

20.

Grant B, Stinson F, Dawson D, Chou S, Dufour M, Compton W . Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2004; 61(8):807-16. DOI: 10.1001/archpsyc.61.8.807. View